Amicus Therapeutics Inc (FOLD)
R&D Expense Growth
1.39%
Quarterly · Period ending:
FOLD R&D Expense Growth
Latest reported1.39%period ending
Latest reported1.39%period ending
FOLD Quarterly R&D Growth (QoQ) (0.00% → 1.39%)
Latest values, visible window
High-resolution chart · PNG
FOLD r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 1.3923% | |
| -61.5189% | |
| 118.5711% | |
| -7.7873% | |
| 15.4052% | |
| 5.9839% | |
| -12.8702% | |
| -19.127% | |
| -13.9421% | |
| 15.8041% | |
| -15.3016% | |
| -35.0269% | |
| 20.5796% | |
| -32.3663% | |
| -3.9231% | |
| -4.7654% | |
| 44.2637% | |
| -5.8251% | |
| -1.7374% | |
| -19.1391% | |
| 12.6017% | |
| 1.1607% | |
| -21.8907% | |
| -3.0377% | |
| 56.0687% | |
| -17.0313% | |
| 9.8896% | |
| 12.8913% | |
| -58.6065% | |
| 298.8084% | |
| -15.0449% | |
| -10.937% | |
| 12.7138% | |
| 27.0627% | |
| 3.5918% | |
| 0.8031% | |
| -5.629% | |
| 77.545% | |
| -21.9594% | |
| 3.5359% | |
| 7.8871% | |
| 21.6839% | |
| 6.9571% | |
| 3.2554% | |
| 29.5128% | |
| 20.7557% | |
| -0.1401% | |
| 9.5614% | |
| -9.7923% | |
| -5.7343% | |
| -10.543% | |
| 8.5272% | |
| -3.9308% | |
| -16.2064% | |
| -2.0066% | |
| -2.7568% | |
| 5.0325% | |
| 18.0151% | |
| 4.4315% | |
| -15.425% | |
| 48.4315% | |
| 8.9099% | |
| -8.4599% | |
| -12.2247% | |
| -19.6844% | |
| -6.392% | |
| 13.4316% | |
| -13.7931% | |
| 67.9878% | |
| -7.3237% | |
| 27.4744% | |
| -28.2213% | |
| 28.3004% | |
| 11.116% | |
| -4.2625% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |